CD20 Protein-VLP (AA 1-297) (Biotin)
-
- 抗原 See all CD20 (MS4A1) 蛋白
- CD20 (MS4A1) (Membrane-Spanning 4-Domains, Subfamily A, Member 1 (MS4A1))
- 蛋白类型
- VLP
- 生物活性
- Active
- 产品特性
- AA 1-297
-
宿主
- 人
-
资源
- HEK-293 Cells
- 标记
- This CD20 protein is labelled with Biotin.
- 应用范围
- Immunogen (Imm), ELISA, Functional Studies (Func), Surface Plasmon Resonance (SPR)
- 原理
- Biotinylated Human CD20 Protein-VLP
- 序列
- Met1-Pro297
- 产品特性
- Recombinant Biotinylated Human CD20 Protein-VLP is expressed from HEK293.It contains Met1-Pro297.
- 纯度
- > 95 % as determined by HPLC
- 过滤
- 0.22 μm filtered
- 内毒素水平
- Less than 1EU per μg by the LAL method.
- Biological Activity Comment
- The affinity constant of 0.68 nM as determined in SPR assay (Biacore T200).
- Top Product
- Discover our top product MS4A1 蛋白
-
想要此Protein的其他选项吗？
!探索我们的预定义定制蛋白和定制蛋白服务！Product表达系统ConjugateOrigin价格从表达系统 HEK-293 CellsConjugate His tagOrigin Human价格从 136,947.45 ¥您的项目需要进一步定制吗？联系我们，了解我们的定制蛋白解决方案
-
Membrane-Spanning 4-Domains, Subfamily A, Member 1 (MS4A1) (AA 141-188) protein (His-Avi Tag)
MS4A1 宿主: 人 宿主: 大肠杆菌（E. Coli） Recombinant > 95 % as determined by Tris-Bis PAGE
Membrane-Spanning 4-Domains, Subfamily A, Member 1 (MS4A1) (AA 141-188) protein (His-Avi Tag,Biotin)MS4A1 宿主: 人 宿主: 大肠杆菌（E. Coli） Recombinant > 95 % as determined by Tris-Bis PAGE
Membrane-Spanning 4-Domains, Subfamily A, Member 1 (MS4A1) (AA 1-297) (Active) protein-VLPMS4A1 宿主: 人 宿主: HEK-293 Cells VLP > 95 % as determined by HPLC Imm, ELISA, Func, SPR Active
Membrane-Spanning 4-Domains, Subfamily A, Member 1 (MS4A1) (AA 1-297) protein (His tag)custom-made MS4A1 宿主: 人 宿主: HEK-293 Cells Recombinant > 90 % as determined by Bis-Tris PAGE, anti-tag ELISA, Western Blot and analytical SEC (HPLC)
Membrane-Spanning 4-Domains, Subfamily A, Member 1 (MS4A1) (AA 1-291) protein (His tag)custom-made MS4A1 宿主: 小鼠 宿主: HEK-293 Cells Recombinant > 90 % as determined by Bis-Tris PAGE, anti-tag ELISA, Western Blot and analytical SEC (HPLC)
Membrane-Spanning 4-Domains, Subfamily A, Member 1 (MS4A1) proteinMS4A1 宿主: 人 宿主: Mammalian Cells MNP Membrane Nanoparticle
Membrane-Spanning 4-Domains, Subfamily A, Member 1 (MS4A1) proteinMS4A1 宿主: 人 宿主: HEK-293 Cells Synthetic Nanodisc
Membrane-Spanning 4-Domains, Subfamily A, Member 1 (MS4A1) (AA 1-297) (Active) protein (His tag)MS4A1 宿主: Cynomolgus 宿主: HEK-293 Cells Recombinant >90 % as determined by SDS-PAGE. Active
Membrane-Spanning 4-Domains, Subfamily A, Member 1 (MS4A1) (AA 1-297) (Active) protein (His tag)MS4A1 宿主: 人 宿主: HEK-293 Cells Recombinant >85 % as determined by SDS-PAGE. Active
Membrane-Spanning 4-Domains, Subfamily A, Member 1 (MS4A1) (AA 141-188) protein (His-IF2DI Tag)MS4A1 宿主: 人 宿主: 大肠杆菌（E. Coli） Recombinant Greater than 95 % as determined by SDS-PAGE WB, ELISA
-
- 应用备注
-
- Antibody Discovery: Immunization, Screening, Functional Characterization
- Affinity determination: ELISA, SPR
- In vivo pharmacokinetic analysis
- CMC method development
- CAR-T Positive Rate Detection
- Blood sample determination: ELISA
- 说明
-
Virus-like particles (VLPs) are formed from the outer capsid protein of a virus and are tiny nanoparticles formed by the automatic assembly of one or more capsid proteins. VLPs do not contain viral infectious genomes, so they are relatively safe during production operations. The SAMS™ protein engineering platform has been used to express a series of biotinylated, non-biotinylated, and fluorescently-labeled VLP-displayed antigens. They are suitable for SPR, ELISA, CAR-T positive rate detection, and other experimental scenarios.
Virus-Like Particles (VLPs) are highly immunogenic, meaning that they can elicit a strong immune response in the host. VLPs are recognized by the immune system and are taken up by antigen-presenting cells (APCs) such as dendritic cells. Once taken up by APCs, VLPs are processed and presented to T cells, which can trigger the activation of B cells to produce antibodies against the displayed antigen. Because VLPs resemble the structure and composition of native viruses, they are highly effective at inducing both humoral and cellular immune responses.
Generally, VLPs range in size from approximately 20 to 200 nanometers (nm). Compared to a cell-based immunization approach, their smaller size can optimize the immune response to target the specific antigen displayed on the surface of the engineered VLPs. - 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- Supplied as 0.22μm filtered solution in PBS ( pH 7.4).
- 储存条件
- -80 °C
- 储存方法
- Valid for 12 months from date of receipt when stored at -80°C., Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
- 有效期
- 12 months
-
- 抗原
- CD20 (MS4A1) (Membrane-Spanning 4-Domains, Subfamily A, Member 1 (MS4A1))
- 别名
- CD20 (MS4A1 产品)
- 背景
- B-lymphocyte antigen CD20 or CD20 is an activated-glycosylated phosphoprotein expressed on the surface of all B-cells beginning at the pro-B phase (CD45R , CD117) and progressively increasing in concentration until maturity.CD20 is the target of the monoclonal antibodies rituximab, ocrelizumab, obinutuzumab, ofatumumab, ibritumomab tiuxetan, tositumomab, and ublituximab, which are all active agents in the treatment of all B cell lymphomas, leukemias, and B cell-mediated autoimmune diseases.
- 分子量
- 34.3 kDa.
-
